Impel NeuroPharma is conducting clinical studies of investigational upper nasal therapies in three diseases: acute migraine, OFF episodes in Parkinson’s disease; and agitation associated with schizophrenia and bipolar I disorder.

 

For more information, follow the links below to the study listings on clinicaltrials.gov.